Stocktoria
OnKure Therapeutics, Inc. OKUR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-04-09
OnKure Therapeutics, Inc. statistics & valuation
Market cap$181.8M
P / B3.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -95.8% | -45.8% | -98.8% | -48.0% | -25.8% |
| Return on equity | -105.9% | -50.7% | 34.7% | 95.5% | -27.0% |
| Current ratio | 10.28 | 10.73 | 4.64 | 14.93 | 24.79 |
Source: SEC EDGAR filings · CIK 0001637715 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.